Executive Director, Head Clinical Development and Quality Operations
About me
Lorraine has over 25 years in the pharmaceutical industry, starting her career as a medicinal chemist with Pfizer and moved into Clinical Quality Assurance 16 years ago. Lorraine is currently Head of Clinical Development and Operations Quality, at BMS where her and her team are responsible for defining, implementing, and overseeing the quality strategy for all Therapeutic Area, process, and vendor and GCP inspection management. The team is also responsible for creation of a quality narrative that can be shared with stakeholders and health authorities. In addition, Lorraine has managed and led numerous FDA/EMA/PMDA Sponsor GCP inspections. Lorraine promotes a proactive quality driven, solution orientated approach to ensure successful submission and inspection readiness for BMS medicines.